Co-Authors
This is a "connection" page, showing publications co-authored by Abdo Elfiky and Ibrahim Ibrahim.
Connection Strength
3.048
-
Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico. J Infect. 2021 May; 82(5):186-230.
Score: 0.925
-
COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect. 2020 05; 80(5):554-562.
Score: 0.871
-
Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective. Biochem Biophys Res Commun. 2021 07 12; 562:89-93.
Score: 0.237
-
COVID-19 and Cell Stress. Adv Exp Med Biol. 2021; 1318:169-178.
Score: 0.230
-
A possible role for GRP78 in cross vaccination against COVID-19. J Infect. 2021 02; 82(2):282-327.
Score: 0.226
-
Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19. Phytomedicine. 2021 May; 85:153310.
Score: 0.225
-
Alkaloids and flavonoids from African phytochemicals as potential inhibitors of SARS-Cov-2 RNA-dependent RNA polymerase: an in silico perspective. Antivir Chem Chemother. 2020 Jan-Dec; 28:2040206620984076.
Score: 0.215
-
Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum. Comput Biol Med. 2021 09; 136:104671.
Score: 0.060
-
Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective. Pharmacol Rep. 2021 Dec; 73(6):1754-1764.
Score: 0.060